Literature DB >> 20466782

Sexual function and surgical outcome in women with congenital adrenal hyperplasia due to CYP21A2 deficiency: clinical perspective and the patients' perception.

Anna Nordenström1, Louise Frisén, Henrik Falhammar, Helena Filipsson, Gundela Holmdahl, Per Olof Janson, Marja Thorén, Kerstin Hagenfeldt, Agneta Nordenskjöld.   

Abstract

CONTEXT: Females with congenital adrenal hyperplasia (CAH) due to a CYP21A2 deficiency are exposed to androgens during fetal development, resulting in virilization of the external genitalia. Little is known about how these women feel that the disease has affected their lives regarding surgery and psychosexual adaptation.
OBJECTIVE: Our objective was to investigate the correlation between the surgical results, the self-perceived severity of the disease, and satisfaction with sexual life and relate the results to the CYP21A2 genotype. DESIGN AND PARTICIPANTS: Sixty-two Swedish women with CAH and age-matched controls completed a 120-item questionnaire, and a composite score for sexual function was constructed. The surgical outcome, including genital appearance and clitoral sensitivity, was evaluated by clinical examination. The patients were divided into four CYP21A2 genotype groups.
RESULTS: The sexual function score, but not for genital appearance, was higher in the patients satisfied with their sexual life. This was also true of the patients who were satisfied with the surgical result. There were discrepancies between the patients' perception of the impact of the condition on their sexual life and what health professionals would assume from clinical examination. The patients in the null genotype group scored lower on sexual function and satisfaction with their sexual life and had more surgical complications, also compared with the slightly less severe I2-splice genotype group.
CONCLUSION: Our data show that the null genotype group was considerably more affected by the condition than the other groups and should be regarded as a subgroup, both psychologically and from a surgical perspective. Genotyping adds clinically valuable information.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20466782     DOI: 10.1210/jc.2009-2639

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  26 in total

1.  Quality of life, social situation, and sexual satisfaction, in adult males with congenital adrenal hyperplasia.

Authors:  Henrik Falhammar; Helena Filipsson Nyström; Marja Thorén
Journal:  Endocrine       Date:  2014-01-10       Impact factor: 3.633

Review 2.  The way toward adulthood for females with nonclassic congenital adrenal hyperplasia.

Authors:  Georgia Ntali; Sokratis Charisis; Christo F Kylafi; Evangelia Vogiatzi; Lina Michala
Journal:  Endocrine       Date:  2021-04-14       Impact factor: 3.633

Review 3.  Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.

Authors:  Krupali Bulsari; Henrik Falhammar
Journal:  Endocrine       Date:  2016-12-07       Impact factor: 3.633

Review 4.  Gender identity, gender assignment and reassignment in individuals with disorders of sex development: a major of dilemma.

Authors:  A D Fisher; J Ristori; E Fanni; G Castellini; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2016-06-10       Impact factor: 4.256

Review 5.  Prenatal treatment of congenital adrenal hyperplasia-not standard of care.

Authors:  Selma Feldman Witchel; Walter L Miller
Journal:  J Genet Couns       Date:  2012-05-26       Impact factor: 2.537

Review 6.  Clinical outcomes in the management of congenital adrenal hyperplasia.

Authors:  Henrik Falhammar; Marja Thorén
Journal:  Endocrine       Date:  2012-01-07       Impact factor: 3.633

Review 7.  Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.

Authors:  Henrik Falhammar; Anna Nordenström
Journal:  Endocrine       Date:  2015-06-17       Impact factor: 3.633

8.  Multidimensional Aspects of Female Sexual Function in Congenital Adrenal Hyperplasia: A Case-Control Study.

Authors:  Maggie Dwiggins; Brittany Brookner; Kylie Fowler; Padmasree Veeraraghavan; Veronica Gomez-Lobo; Deborah P Merke
Journal:  J Endocr Soc       Date:  2020-09-04

Review 9.  Biochemical and genetic diagnosis of 21-hydroxylase deficiency.

Authors:  Henrik Falhammar; Anna Wedell; Anna Nordenström
Journal:  Endocrine       Date:  2015-09-04       Impact factor: 3.633

10.  [Congenital adrenal hyperplasia in girls/young women].

Authors:  S Krege
Journal:  Urologe A       Date:  2014-02       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.